Skip to main content

HTRF CHO HCP Detection Kit, 10,000 Assay Points

The CHO Host Cell Protein kit is designed for the quantitative assessment of Chinese Hamster Ovary (CHO) cell contaminants in bioprocess operations.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein Quantification
Sample Volume 16 µL

The CHO Host Cell Protein kit is designed for the quantitative assessment of Chinese Hamster Ovary (CHO) cell contaminants in bioprocess operations.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

The CHO Host Cell Protein (HCP) kit measures contaminants originating from the CHO cells used to manufacture therapeutic antibodies. The kit can be used for the quantification of CHO HCP proteins in routine bioprocess operations, from the completely raw harvest material to the final product. The simple and robust procedure benefits from increased throughput compared to ELISA.

Specifications

Application
Protein Quantification
Automation Compatible
Yes
Brand
HTRF
Detection Modality
HTRF
Product Group
Kit
Sample Volume
16 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Biomarkers
Technology
TR-FRET
Therapeutic Area
Cardiovascular
Infectious Diseases
Metabolism/Diabetes
NASH/Fibrosis
Neuroscience
Rare Diseases
Unit Size
10,000 Assay Points

Video gallery

How it works

Assay principle

The CHO Host Cell Protein (HCP) assay is a sandwich immunoassay. The assay uses a specific and qualified anti-CHO HCP polyclonal antibody pool, labelled with Eu3+-Cryptate and t d2. The specific signal is proportional to the concentration of CHO HCP present in the sample. This homogeneous assay requires only a single reagent addition (by premixing the detection reagents), and an overnight incubation, for the quantitative detection of CHO HCP.

host-cell-protein-detection-kit

 

Assay protocol

The CHO HCP assay protocol, using a 384-well small volume white plate, is described on the right. 16 µL of sample or standard are dispensed directly into the detection plate for detection by HTRF® reagents. The antibodies labeled with the HTRF donor and acceptor can be pre-mixed and added in a single dispensing step, to further streamline the assay procedure. This protocol requires only 1 overnight incubation period.

host-cell-protein-detection-kit

 

Assay details

HTRF CHO HCP assay specifications
Sample volume 16 µL
Final assay volume 20 µL
Time to results Overnight at RT
Detection limit 0.8 ng/mL
Dynamic range 3.6 to 400 ng/mL
Sample compatibility From raw harvest material to the final biotherapeutic product

 

host-cell-protein-detection-kit

 

HTRF CHO HCP assay specifications
host-cell-protein-detection-kit

 

Analytical performance

Precision

Intra-assay (n=24)

Sample Mean [CHO HCP] (ng/mL) % CV
1 10 6%
2 29 3%
3 97 3%
4 306 4%

Each of the 4 samples was measured 24 times, and the %CV on concentration was calculated for each sample.

 

Inter-assay (n=4)

Sample Mean [CHO HCP] (ng/mL) %CV
1 10 9%
2 29 5%
3 97 4%
4 292 5%

Each of the 4 samples was measured in 4 independent experiments by 4 different operators, and the  concentration % CV was calculated for each sample.

 

Antigen spike and recovery
Sample [CHO HCP Standard] (ng/mL) [CHO-DG44 HCP Sample] added (ng/mL) Expected [CHO HCP] (ng/mL) Measured [CHO HCP] (ng/mL) % Antigen recovery
1 13.51 7.04 20.55 21.38 104%
2 13.51 14.07 27.58 27.92 101%
3 13.51 23.38 36.89 41.25 112%
4 45.55 26.04 71.59 69.45 97%
5 45.55 45.06 90.61 94.08 104%
6 45.55 88.02 133.57 137.62 103%
7 95.11 45.06 140.17 150.64 107%
8

95.11

 

88.02 183.13 202.40 111%
9 95.11 161.56 256.67 279.14 109%

Three different levels of CHO HCP Standard were independently mixed with three different sample concentrations (cell culture supernatant from a biomanufacturing process using the CHO-DG44 cell line). The total measured concentrations were compared to the theoretical ones, and expressed as % Antigen recovery (acceptance criteria: 85-115%).

CHO-S HCP sample

Dilution Factor Expected [CHO HCP] (ng/mL) Measured [CHO HCP] (ng/mL) % Recovery
Neat 426 426 100%
2 213 226 106%
4 106 111 104%
8 53 57 106%
16 27 28 107%
32 13 13 98%
64 7 7 101%
128 3 4 106%

Samples were from cell culture supernatant from a biomanufacturing process using the CHO-S cell line diluted in the kit's Diluent 5. The recovery % obtained from these experiments show the good dilutional linearity of the assay (dilution test acceptance criteria: 80-120%)

 

CHO-K1 HCP sample

Dilution Factor Expected [CHO HCP] (ng/mL) Measured [CHO HCP] (ng/mL) % Recovery
Neat 344 344 100%
2 172 173 100%
4 86 88 102%
8 43 45 105%
16 22 24 111%
32 11 13 119%

Samples were from cell culture supernatant from a biomanufacturing process using the CHO-K1 cell line and diluted in the kit's Diluent #5. The recovery % obtained from these experiments show the good dilutional linearity of the assay (dilution test acceptance criteria: 80-120%)

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-5 of 5 Resources
Application Note Icon
Application Note
Advantages of using our automatable and no-wash HTRF and AlphaLISA kits for CHO HCP detection

Detecting and quantifying HCPs with automatable homogeneous immunoassays

During biotherapeutic manufacturing and production, the...

Whitepaper Icon
Whitepaper
Exploring the strengths, challenges, and therapeutic applications of multispecific antibodies

Unlock the future of therapeutics with multispecific antibodies

Discover the groundbreaking advancements in multispecific antibody...

Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Infographic Icon
Infographic
Safety rules with Revvity biotherapeutic workflows

Helping you put safety and product efficacy at the forefront of your GMP manufacturing

At Revvity we’re able to support your GMP...

Guide Icon
Guide
The issue of CHO HCPs during biopharmaceutical production

Detecting and quantifying CHO HCPs with automatable homogeneous immunoassays

In recent years recombinant therapeutic proteins and...

Scroll Icon